logo-loader
Collagen Solutions PLC

Investor presentation

/**/ link{ color: blue }visited{ color: #954F72 } .ag{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.ag{}p.bf{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin:0cm;margin-bottom:.0001pt}span.bg{color: black; font-family: "Calibri","sans-serif"; font-size: 11.0pt; font-weight: bold}p.bh{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin: 0cm; margin-bottom: .0001pt; text-align: center}p.bi{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin: 0cm; margin-bottom: .0001pt; text-align: center}span.bj{font-size:11.0pt;font-family:"Calibri","sans-serif"; color:black}span.bk{font-size:11.0pt;font-family:"Calibri","sans-serif"; color:black}p.bl{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin: 0cm; margin-bottom: .0001pt; text-align: center}span.bm{color: black; font-family: "Calibri","sans-serif"; font-size: 11.0pt; font-weight: bold} p.bn{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin:0cm;margin-bottom:.0001pt}span.bo{color: black; font-family: "Calibri","sans-serif"; font-size: 11.0pt; font-weight: bold}p.bp{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin:0cm;margin-bottom:.0001pt;text-align:justify}span.az{font-size:11.0pt;font-family:"Calibri","sans-serif";color:black}span.ax{font-size:11.0pt;font-family:"Calibri","sans-serif"}span.ay{color:black}p.bq{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal}span.br{color:black}p.bs{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin:0cm;margin-bottom:.0001pt;text-align:justify}span.bt{font-size:11.0pt;font-family:"Calibri","sans-serif"} span.bu{font-size:11.0pt;font-family:"Calibri","sans-serif"}p.bv{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;line-height: normal}p.bw{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: justify}table.bx{width:490.5pt;margin-left:-5.4pt;border-collapse:collapse}td.ar{width:225.9pt;padding:0cm 5.4pt 0cm 5.4pt}p.by{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;font-weight: bold; line-height: normal; margin-bottom: 0cm}td.ap{width:243.0pt; padding:0cm 5.4pt 0cm 5.4pt}p.bz{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;margin-bottom:0cm;margin-bottom:.0001pt; line-height:normal}p.ca{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;line-height: normal; margin-bottom: 0cm; text-align: right}td.an{width:249.95pt; padding:0cm 5.4pt 0cm 5.4pt} td.am{width:218.95pt;padding:0cm 5.4pt 0cm 5.4pt}td.al{width:237.65pt; padding:0cm 5.4pt 0cm 5.4pt}td.ak{width:231.25pt; padding:0cm 5.4pt 0cm 5.4pt}span.aj{color:#0070C0}td.ai{border:none}p.a,li.a,div.a{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";} /**/
RNS Number : 9112Z
Collagen Solutions PLC
23 May 2019
 

23 May 2019

Collagen Solutions plc

("Collagen Solutions" or the "Company")

 

ShareSoc Growth Company Seminar

 

Collagen Solutions Plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces it will be presenting at the ShareSoc Growth Company Seminar in Manchester on Tuesday, 4 June 2019.

 

Jamal Rushdy, CEO, will provide a company overview, highlighting the positive momentum as announced in the April Trading Update as well as plans for future growth.

 

The event will take place at the DoubleTree by Hilton Hotel, One Piccadilly Place, 1 Auburn Street, Manchester, M1 3DG. Registration will open at 6.00pm.

 

Further details of the event, along with a registration form, are available at:

 

https://www.sharesoc.org/events/sharesoc-growth-company-seminar-in-manchester-4-june-2019/

 

Enquiries:

Collagen Solutions Plc

 

Jamal Rushdy, CEO 

Via Walbrook

Hilary Spence, CFO

 

 

 

Cenkos Securities Plc (Nominated Adviser and Broker)

Tel: 0207 397 8900

Giles Balleny / Stephen Keys

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or [email protected] 

Anna Dunphy

Mob: 07876 741 001

Helen Cresswell

Mob: 07841 917 679

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NRAKMGZKVZDGLZM

Quick facts: Collagen Solutions PLC

Price: £0.04

Market: LSE
Market Cap: £16.86 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Collagen Solutions sees clear path to profitability as commercial...

Collagen Solutions PLC's (LON:COS) Jamal Rushdy and Hilary Spence talk Proactive London's Andrew Scott through the firm's results for the year ended 31 March 2019. Revenues were up 22% in the year at £4.5mln, while its loss narrowed by just under £500,000 to £1.22mln. The core...

on 11/7/19